Journal articleSci Transl Med2025
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer.
- Journal
- Sci Transl Med
- Published
- 3 September 2025
- Citations
- 12
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 8
- Core C-Computational Core P01CA117969↗
- Project 3: Mechanisms and therapeutic targeting of NRAS in melanoma P01CA203657↗
- Tumor Biology P30CA125123↗
- Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy P50CA196510↗
- Biological Activity of Ras Oncogenes R01CA042978↗
- Mechanisms of PAK1 activation, signaling and tumor resistance R01CA175747↗
- Targeting undruggable RAS for cancer treatment R35CA232113↗
- Identification of synthetic lethal interactors in pancreatic cancer U01CA199235↗